Vivagyn voie orale
Food supplement declared in France, declaration No 2023-10-702
Vivagyn voie orale is a food supplement declared in France. Status: earlier declaration, replaced by the 2025 declaration. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- Laboratoires DENSMORE
- Status
- Earlier declaration, replaced by the 2025 declaration : Vivagyn voie orale
- Form
- Capsule
- Daily dose
- 1 gélule
- Directions for use
- 1 gélule par jour
- Intended populations
- Women
Declaration 135696, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Micro-organisms
| Strain | Per day |
|---|---|
| Lactobacillus Plantarum Plantarum | 5,000,000,000 (unit not declared) |
| Lactobacillus Rhamnosus Rhamnosus | 1,000,000,000 (unit not declared) |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Riboflavine | Vitamine B2 (riboflavine) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Cholécalciférol | Vitamine D | 100 µg (4,000 UI) | 5 µg (200 UI) |
Additives
E470b, E300
Other ingredients
amidon, Gélule végétale
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Vivagyn voie orale Laboratoires DENSMORE, declared in 2025 : different composition: 1 ingredient(s) added, 0 missing
- Vivagyn voie orale Laboratoire Densmore Belgium, declared in 2022, withdrawn from the market : different composition: 1 ingredient(s) added, 2 missing
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.